Overview of Dr. Rohs
Dr. Nicholas Rohs is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. He received his medical degree from New York Medical College and has been in practice 6 years. He is one of 122 doctors at Mount Sinai Beth Israel and one of 87 doctors at Mount Sinai Morningside who specialize in Oncology. He has 9 publications and over 100 citings.
Office
325 W 15th St
New York, NY 10011Fax+1 212-604-6038
Education & Training
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2011 - 2014
- New York Medical CollegeClass of 2011
Certifications & Licensure
- NY State Medical License 2014 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Dupilumab_Metastatic NSCLC Start of enrollment: 2021 Sep 10
Roles: Contact
Publications & Presentations
PubMed
- Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections.Medha Somisetty, Philip C Mack, Chih-Yuan Hsu, Yuanhui Huang, Jorge E Gomez
Clinical Lung Cancer. 2024-11-01 - 1 citationsAdverse Event Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer: An Updated Meta-analysis.Susu Zhou, Noriko Kishi, Parissa Alerasool, Nicholas C Rohs
Targeted Oncology. 2024-07-01 - Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer.Philip C Mack, Chih-Yuan Hsu, Ananda M Rodilla, Jorge E Gomez, Jazz Cagan
Vaccines. 2024-06-26
Press Mentions
- How Air Pollution Can Trigger NSCLC in Never-SmokersOctober 4th, 2022
- Is Disease-Free Survival a Meaningful Endpoint in NSCLC?June 25th, 2021
- Comprehensive Biomarker Testing for Lung Cancer: Who Needs It & What’s It For?August 17th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: